Shares of TherapeuticsMD Inc. (TXMD) are soaring over 17% in pre-market today, after the company announced that the United States Patent and Trademark Office has issued a patent that covers the labeled indication for ANNOVERA, the first and only long-lasting, patient-controlled, procedure-free, reversible prescription contraceptive option for women.
from RTT - Before the Bell https://ift.tt/2W7J1yN
via IFTTT
No comments:
Post a Comment